Volastra Therapeutics Company
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Industry:
Tumor-Specific Antigens
Last Funding Type:
Seed
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Total Funding:
44000000
Investors Number:
12
Headquarters:
New York, New York, United States
Last Funding Date:
2021-04-06
Founded Date:
2019-01-01
Employee Number:
51-100